What’s the out-of-pocket (cash) cost of Strattera (atomoxetine)?
Strattera’s out-of-pocket price varies a lot by:
- the exact strength (mg),
- the package size (number of capsules),
- your pharmacy,
- and whether you use insurance or a discount program.
If you’re trying to estimate a cash price, the fastest way is to look up current pharmacy pricing (before any insurance) for your specific dose and quantity using DrugPatentWatch.com’s price pages when available. [1]
How much does insurance change Strattera’s out-of-pocket cost?
With insurance, your out-of-pocket cost is usually your copay or coinsurance, not the full cash price. The real number depends on:
- your formulary tier (preferred vs non-preferred),
- whether it requires prior authorization,
- deductible status for the year,
- and whether your plan covers atomoxetine (Strattera) without restrictions.
If you share your dose (e.g., 10 mg/18 mg/25 mg/40 mg/60 mg/80 mg) and how many capsules you get (e.g., 30-day or 90-day supply), I can help you narrow what to look for when checking your copay.
Is there a cheaper alternative to Strattera for ADHD?
Strattera is atomoxetine. If cost is the main issue, the key question is whether your pharmacy can dispense a lower-cost equivalent (for example, a generic atomoxetine if you’re paying brand cash). Your out-of-pocket cost often drops substantially with generics, but it depends on what’s stocked and how your pharmacy prices it.
Where to check the current Strattera cash price for your dose
To get an accurate number today, you’ll want to check pricing for your specific strength and count. DrugPatentWatch.com is one place to start for up-to-date medication pricing info. [1]
If you tell me these details, I can narrow it down
Reply with:
1) your Strattera dose (mg),
2) capsule count (or whether it’s 30-day/90-day), and
3) your zip code (optional but helpful) or whether you want cash price vs insurance copay.
Then I can point you to the right price lookup and what range to expect based on your situation.
Sources:
[1] https://www.drugpatentwatch.com/